Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid.

Basit Öğe Kaydı
dc.contributor.authorEmingil G.
dc.contributor.authorGürkan A.
dc.contributor.authorAtilla G.
dc.contributor.authorKantarci A.
dc.date.accessioned2019-10-27T08:34:10Z
dc.date.available2019-10-27T08:34:10Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.description.abstractThe present randomized, double-masked, placebo-controlled, parallel-arm study examines the impact of adjunctive subantimicrobial-dose doxycycline (SDD) on the local inflammatory response through cytokine and chemokine levels in gingival crevicular fluid (GCF) samples from patients with chronic periodontitis. Forty-six patients with chronic periodontitis received scaling and root planing with or without adjunctive SDD. GCF samples were collected and clinical parameters including probing depth, clinical attachment level, gingival index, and plaque index were recorded every 3 months for 12 months. GCF tumor necrosis factor-?, interleukin (IL)-6, IL-4, IL-10, IL-13, IL-17, macrophage inhibitory protein 1?, macrophage inhibitory protein 1ß, monocyte chemoattractant protein 1, and regulated on activated normal T-cell expressed and secreted protein levels were determined by xMAP multiplex immunoassay. Significant improvements were observed in all clinical parameters in both groups over 12 months (P <0.0125), whereas the SDD group showed significantly better reduction in gingival index, probing depth, and gain in clinical attachment compared to the placebo group (P <0.05). Decrease in IL-6 in the SDD group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-? was significantly reduced in moderately deep pockets (P <0.05). SDD resulted in a stable IL-4 and IL-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05). These results show that SDD, as an adjunct to non-surgical periodontal therapy, stabilizes the inflammatory response by promoting the suppression of proinflammatory cytokines and increasing the anti-inflammatory cytokines. The chemokine activity would account for the regulation of the inflammatory response to SDD therapy.en_US
dc.identifier.doi10.1902/jop.2010.100036en_US
dc.identifier.endpage461en_US
dc.identifier.issn1943-3670
dc.identifier.issue3en_US
dc.identifier.pmid20932155en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage452en_US
dc.identifier.urihttps://doi.org/10.1902/jop.2010.100036
dc.identifier.urihttps://hdl.handle.net/11454/26984
dc.identifier.volume82en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofJournal of periodontologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSubantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid.en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu